A supplementation of DHA and AA to human milk-fed VLBW infants has no significant cognitive improvement or measurable neuroanatomical effects when evaluated at 8 years of age.
Department of Neonatology, Jagiellonian University Cracow, Cracow, Poland.
Ryszard
R
Lauterbach
D016718:Arachidonic Acid / Q000627:therapeutic use*; D001921:Brain / Q000033:anatomy & histology*; D003071:Cognition / Q000502:physiology*; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000627:therapeutic use*; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male
D005231:Fatty Acids, Unsaturated; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid